Search Results for "Qvint Biotech As"
Original Source: Qvint Biotech AS
Qvint Biotech AS is an early-stage and privately held biotechnology company founded June 2005. We are dedicated to serve the life-science market with products that meet current and future demands.Qvint Biotech’s Vision is “Making Science Easy!”Today, many advanced scientific applications are available to a limited number of users due to barriers such as need for special competence or cost issues. Qvint Biotech’s Mission is to provide functional, user-friendly and well-designed products to the life-s...
Matching Channels
Able to take advantage of a €2 European funding stimulus in 2009, the Czech Republic is one of Europe's top 5 centers for biotechnology companies. In just over decade, the Czech Republic ha...
India, in the Asian subcontinent is the world’s fourth largest producer of pharmaceuticals, and is thought as one of the most promising biotech markets in the world. Several important steps...
In addition to the Silicon Valley, California on the west coast of the USA is home to a biotechnology hub. 26% of all American biotechnology firms are located in this state, but they count for over...
Carolina, on the southeastern US coast is a hotbed for biotechnology companies. The regional industry support organization, The North Carolina Biotechnology Center, is the oldest of its type in th...
Matching News
The Entrepreneurial Diaspora Enabled By Biotech M&A
The recycling of equity capital through realized returns is a critically important element of biotech investing. When public biotech companies get bought, like Genentech by Roche, or smaller deals l...
Biotech crops gaining worldwide acceptance
For the first time since the introduction of biotech crops almost two decades ago, developing countries grew biotech crops on more land than in industrialized countries in 2012, according to a report...
Agila Biotech to Set Up Biotech Facility at Malaysia's Bio-XCell Ecosystem
Agila Biotech aims for the R&D and manufacturing facilities to be operational by end-2014.
Übernahme von BB Biotech abgesagt
Die Biotech-Beteiligungsgesellschaft BB Biotech bleibt eigenständig. Ein Übernahmeversuch der...
More Farmers Around the World Plant Biotech Crops
ISAAA (International Service for the Acquisition of Agri-Biotech Applications) released their annual report last week on the Global Status of Commercialized Biotech/GM Crops: 2012, showing a record 17...
How To Build a Biotech Cluster That Isn’t Boston or SF
I live and work in Louisville, KY, a city that probably isn’t too different from a lot of communities in the U.S. that are not biotech hubs like San Francisco and Boston. Driven in part by economic...
Marina Biotech licenses nucleic acid chemistry to Novartis
Marina Biotech, Inc has entered into a licensing agreement with Novartis for Marina Biotech’s Conformationally Restricted Nucleotide (CRN) technology for the development of both single- and double-s...
Delicious Irony: What If Biotech Crops Actually Helped Organic?
A lot has been written about the “battle” between biotech and organic. Organic proponents claim biotech is a big evil – complicated technology invented by large-scale corporate agriculture to...
Matching PubMed Articles
Biotech 101: An Educational Outreach Program in Genetics and Biotechnology.
Recent advances in research and biotechnology are making genetics and genomics increasingly relevant to the lives and health of the general public. For the public to make informed healthcare and publi...
Industry progress report on neuro-oncology: a biotech update.
With steadily rising revenue and large numbers of clinical trials utilizing novel treatment strategies, the field of neuro-oncology is at the core of the growing cancer therapy industry. In June 2012,...
